Literature DB >> 16535567

Purification and Characterization of a Lovastatin Esterase from Clonostachys compactiuscula.

T G Schimmel, W S Borneman, M J Conder.   

Abstract

An esterase from the fungus Clonostachys compactiuscula selectively hydrolyzes lovastatin, a clinically useful antihypercholesterolemic agent. Lovastatin or lovastatin-related compounds were required to induce the activity of the lovastatin 8(prm1)-((alpha)-methylbutyryloxy) esterase. The 46-kDa esterase was purified from mycelial extracts by centrifugation and a single anion-exchange chromatographic separation. Maximal lovastatin esterase activity was found at pH 9.0 to 9.6 and at 25 to 30(deg)C. The addition of 5 to 20% methanol resulted in greater lovastatin hydrolysis, while the addition of other solvents (ethanol, isopropanol, butanol, ethyl acetate, isopropyl acetate, or tetrahydrofuran) decreased hydrolysis. Lovastatin was selectively hydrolyzed even in the presence of an excess of simvastatin, another antihypercholesterolemic agent that is structurally very similar to lovastatin. This lovastatin 8(prm1)-((alpha)-methylbutyryloxy) esterase can be used to prepare a core intermediate for the generation of novel antihypercholesterolemic agents or to purify simvastatin prepared by C methylation of the 2(S)-methylbutyryloxy side chain of lovastatin.

Entities:  

Year:  1997        PMID: 16535567      PMCID: PMC1389545          DOI: 10.1128/aem.63.4.1307-1311.1997

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  21 in total

1.  ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium.

Authors:  A Endo; M Kuroda; Y Tsujita
Journal:  J Antibiot (Tokyo)       Date:  1976-12       Impact factor: 2.649

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Microbial conversion of compactin (ML-236B) to ML-236A.

Authors:  D Komagata; H Yamashita; A Endo
Journal:  J Antibiot (Tokyo)       Date:  1986-11       Impact factor: 2.649

4.  3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin.

Authors:  W F Hoffman; A W Alberts; P S Anderson; J S Chen; R L Smith; A K Willard
Journal:  J Med Chem       Date:  1986-05       Impact factor: 7.446

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  The clinical efficacy and safety of lovastatin and MK-733--an overview.

Authors:  J F Walker; J A Tobert
Journal:  Eur Heart J       Date:  1987-08       Impact factor: 29.983

7.  Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

Authors:  A Endo
Journal:  J Antibiot (Tokyo)       Date:  1979-08       Impact factor: 2.649

8.  New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.

Authors:  J A Tobert
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

Review 9.  Discovery, biochemistry and biology of lovastatin.

Authors:  A W Alberts
Journal:  Am J Cardiol       Date:  1988-11-11       Impact factor: 2.778

10.  3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 5. 6-(Fluoren-9-yl)- and 6-(fluoren-9-ylidenyl)-3,5-dihydroxyhexanoic acids and their lactone derivatives.

Authors:  G E Stokker; A W Alberts; J L Gilfillan; J W Huff; R L Smith
Journal:  J Med Chem       Date:  1986-05       Impact factor: 7.446

View more
  2 in total

1.  Efficient synthesis of simvastatin by use of whole-cell biocatalysis.

Authors:  Xinkai Xie; Yi Tang
Journal:  Appl Environ Microbiol       Date:  2007-02-02       Impact factor: 4.792

2.  Structural insights into the catalytic mechanism of lovastatin hydrolase.

Authors:  Yajing Liang; Xuefeng Lu
Journal:  J Biol Chem       Date:  2019-12-15       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.